New Zofran (ondansetron) Lawsuit Filed in Louisiana

At the forefront of the Zofran (ondansetron) litigation since its inception, law firm Grant & Eisenhofer has filed one of the latest Zofran (ondansetron) lawsuits in the Eastern District of Louisiana on behalf of Alexis Alexander and her son who was born with birth defects. The suit alleges that GlaxoSmithKline, maker of Zofran (ondansetron), marketed the anti-nausea medication for unapproved uses, or “off label,” to pregnant women. Upon taking Zofran (ondansetron) for morning sickness in the beginning of her pregnancy, Alexander’s son was born with several congenital heart and lung defects. Alexander’s lawsuit is one of the many that have been filed all over the country alleging similar claims that GlaxoSmithKline unlawfully promoted the drug to expectant mothers, despite evidence, according to the lawsuit, that Zofran (ondansetron) has caused birth defects as early as 1992.

Real Time Analytics